Repligen Corp vs. Taysha Gene Therapies, Inc. Common Stock
Repligen Corp and Taysha Gene Therapies, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| RGEN | TSHA | |
|---|---|---|
| Market Cap | $11.14 billion | $1.28 billion |
RGEN leads on 1 of 1 size & scale factors.
Risk & Sentiment
| RGEN | TSHA | |
|---|---|---|
| Short Interest | 7.13% | 0.08% |
TSHA leads on 1 of 1 risk & sentiment factors.
Dig deeper: RGEN overview, RGEN financials, TSHA overview, TSHA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.